Pierre Giglio

7PUBLICATIONS
50CO-AUTHORS
Molecular targetsRadiation therapyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 28, 2025
Targeting TGFβ docking receptor glycoprotein A repetitions predominant (GARP) via novel chimeric antigen receptor (CAR)-T cell platform to treat glioblastoma.

Bill Xingjun Wu, Daniel Kreatsoulas, Hakan Cam

|Mar 26, 2025
Phase 1 trial of hypofractionated stereotactic re-irradiation in combination with nivolumab, ipilimumab, and bevacizumab for recurrent high-grade gliomas.

Solmaz Sahebjam, Raju R Raval, Peter A Forsyth

|Feb 21, 2025
Early Repeat Residual Resection Versus Adjuvant Therapy for Incompletely Resected Glioblastoma: A Case-Control Study.

Mark A Damante, Joshua Vignolles-Jeong, Guilherme Finger

|Mar 18, 2024
Final report of the phase II NEXT/CNS-GCT-4 trial: GemPOx followed by marrow-ablative chemotherapy for recurrent intracranial germ cell tumors.

Margaret Shatara, Megan Blue, Joseph Stanek

|Feb 26, 2024
Unsupervised machine learning models reveal predictive clinical markers of glioblastoma patient survival using white blood cell counts prior to initiating chemoradiation.

Wesley Wang, Zeynep Temerit Kumm, Cindy Ho

|Mar 27, 2023
Multicenter Phase II Trial of the PARP Inhibitor Olaparib in Recurrent IDH1- and IDH2-mutant Glioma.

Kristina Fanucci, Mary Jo Pilat, Derek Shyr

Pageof 2

Frequent Collaborators

3 joint publications

Vinay Puduvalli

2 joint publications

Zihai Li

1 joint publications

Hannah Rinehardt

1 joint publications

Mahmoud Kassem